| scholarly article | Q13442814 |
| P2093 | author name string | H Lior | |
| G Delage | |||
| F Proulx | |||
| L Lafleur | |||
| J P Turgeon | |||
| L Chicoine | |||
| P2860 | cites work | Subpopulation state of T and B lymphocytes in hemolytic-uremic syndrome in children | Q33360721 |
| Detection of serum and faecal antibodies in haemorrhagic colitis caused by Escherichia coli O157. | Q54647305 | ||
| Verotoxin receptor glycolipid in human renal tissue. | Q54736253 | ||
| Evidence for participation of the macrophage in Shiga-like toxin II-induced lethality in mice | Q64128985 | ||
| Randomized, controlled trial of antibiotic therapy for Escherichia coli O157:H7 enteritis | Q33369842 | ||
| Serological identification of Escherichia coli O157:H7 infection in haemolytic uraemic syndrome | Q33371235 | ||
| The Epidemiology of Infections Caused by Escherichia coli O157: H7, Other Enterohemorrhagic E. coli, and the Associated Hemolytic Uremic Syndrome | Q33375970 | ||
| High incidence of serum antibodies to Escherichia coli O157 lipopolysaccharide in children with hemolytic-uremic syndrome | Q33381234 | ||
| Expression of glycolipid receptors to Shiga-like toxin on human B lymphocytes: a mechanism for the failure of long-lived antibody response to dysenteric disease | Q33385639 | ||
| Haemolytic uraemic syndromes in the British Isles 1985-8: association with verocytotoxin producing Escherichia coli. Part 1: Clinical and epidemiological aspects | Q33397726 | ||
| Serum antibodies to Escherichia coli serotype O157:H7 in patients with hemolytic uremic syndrome | Q33426514 | ||
| Hemolytic uremic syndrome and diarrhea in Argentine children: the role of Shiga-like toxins | Q33428528 | ||
| Antibodies to Escherichia coli O157 in patients with haemorrhagic colitis and haemolytic uraemic syndrome | Q33429198 | ||
| The shiga-like toxin-producing Escherichia coli and hemolytic uremic syndrome | Q33429601 | ||
| Lytic anti-endothelial cell antibodies in haemolytic-uraemic syndrome | Q33444115 | ||
| Anticytotoxin-neutralizing antibodies in immune globulin preparations: potential use in hemolytic-uremic syndrome | Q33445938 | ||
| Vero cytotoxin-producing strains of Escherichia coli from children with haemolytic uraemic syndrome and their detection by specific DNA probes | Q33449435 | ||
| The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli | Q33457864 | ||
| Patients with haemolytic uraemic syndrome caused by Escherichia coli O157: absence of antibodies to Vero cytotoxin 1 (VT1) or VT2. | Q33493218 | ||
| Cloning and sequencing of a Shiga-like toxin type II variant from Escherichia coli strain responsible for edema disease of swine | Q36215407 | ||
| Infection by verocytotoxin-producing Escherichia coli | Q36634680 | ||
| Characterization of flagella purified from enterohemorrhagic, vero-cytotoxin-producing Escherichia coli serotype O157:H7. | Q37151695 | ||
| Purification of the Polymyxin-Released, Heat-Labile Enterotoxin of Escherichia coli | Q39979765 | ||
| Bacterial endotoxin both enhances and inhibits the toxicity of Shiga-like toxin II in rabbits and mice | Q40160063 | ||
| Purification of an Escherichia coli serogroup O157:H7 verotoxin and its detection in North American hemorrhagic colitis isolates. | Q40200609 | ||
| Sensitive method for detecting low numbers of verotoxin-producing Escherichia coli in mixed cultures by use of colony sweeps and polymyxin extraction of verotoxin | Q40204465 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Escherichia coli | Q25419 |
| P304 | page(s) | 136-140 | |
| P577 | publication date | 1995-05-01 | |
| P1433 | published in | Canadian Journal of Infectious Diseases & Medical Microbiology | Q5030243 |
| P1476 | title | Immune response to verotoxin 1 and 2 in children with Escherichia coli O157:H7 hemorrhagic colitis and classic hemolytic uremic syndrome | |
| P478 | volume | 6 |
| Q30453237 | Essential role for verotoxin in sustained stress-activated protein kinase and nuclear factor kappa B signaling, stimulated by Escherichia coli O157:H7 in Vero cells. | cites work | P2860 |
Search more.